Ruthirakuhan M - Search Results

1

Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation.

Ruthirakuhan M, Herrmann N, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE, Kiss A, Lanctôt KL. Ruthirakuhan M, et al. J Geriatr Psychiatry Neurol. 2020 Jul;33(4):175-184. doi: 10.1177/0891988719874118. Epub 2019 Sep 23. J Geriatr Psychiatry Neurol. 2020. PMID: 31547752 Review.

2

Latrepirdine for Alzheimer's disease.

Chau S, Herrmann N, Ruthirakuhan MT, Chen JJ, Lanctôt KL. Chau S, et al. Cochrane Database Syst Rev. 2015 Apr 21;2015(4):CD009524. doi: 10.1002/14651858.CD009524.pub2. Cochrane Database Syst Rev. 2015. PMID: 25897825 Free PMC article. Review.

3

Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.

Liu CS, Chau SA, Ruthirakuhan M, Lanctôt KL, Herrmann N. Liu CS, et al. Among authors: ruthirakuhan m. CNS Drugs. 2015 Aug;29(8):615-23. doi: 10.1007/s40263-015-0270-y. CNS Drugs. 2015. PMID: 26271310 Review.

4

A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer Disease.

Herrmann N, O'Regan J, Ruthirakuhan M, Kiss A, Eryavec G, Williams E, Lanctôt KL. Herrmann N, et al. Among authors: ruthirakuhan m. J Am Med Dir Assoc. 2016 Feb;17(2):142-7. doi: 10.1016/j.jamda.2015.08.019. Epub 2015 Oct 9. J Am Med Dir Assoc. 2016. PMID: 26482056 Free article. Clinical Trial.

5

Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments.

Liu CS, Ruthirakuhan M, Chau SA, Herrmann N, Carvalho AF, Lanctôt KL. Liu CS, et al. Among authors: ruthirakuhan m. Curr Alzheimer Res. 2016;13(10):1134-44. doi: 10.2174/1567205013666160502122933. Curr Alzheimer Res. 2016. PMID: 27137221 Review.

6

Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.

Ruthirakuhan M, Herrmann N, Suridjan I, Abraham EH, Farber I, Lanctôt KL. Ruthirakuhan M, et al. Expert Opin Pharmacother. 2016 Dec;17(18):2417-2429. doi: 10.1080/14656566.2016.1258060. Epub 2016 Nov 22. Expert Opin Pharmacother. 2016. PMID: 27825018 Review.

7

Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia.

Sherman C, Ruthirakuhan M, Vieira D, Lanctôt KL, Herrmann N. Sherman C, et al. Among authors: ruthirakuhan m. Curr Opin Psychiatry. 2018 Mar;31(2):140-146. doi: 10.1097/YCO.0000000000000399. Curr Opin Psychiatry. 2018. PMID: 29256923 Review.

8

Pharmacological interventions for apathy in Alzheimer's disease.

Ruthirakuhan MT, Herrmann N, Abraham EH, Chan S, Lanctôt KL. Ruthirakuhan MT, et al. Cochrane Database Syst Rev. 2018 May 4;5(5):CD012197. doi: 10.1002/14651858.CD012197.pub2. Cochrane Database Syst Rev. 2018. PMID: 29727467 Free PMC article. Review.

9

Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review.

Ruthirakuhan M, Lanctôt KL, Di Scipio M, Ahmed M, Herrmann N. Ruthirakuhan M, et al. Alzheimers Dement. 2018 Oct;14(10):1344-1376. doi: 10.1016/j.jalz.2018.04.013. Epub 2018 Jun 23. Alzheimers Dement. 2018. PMID: 29940162

10

Psychometric properties of apathy scales in Parkinson's disease: a systematic review.

Mohammad D, Ellis C, Rau A, Ruthirakuhan M, Lanctôt KL, Herrmann N. Mohammad D, et al. Among authors: ruthirakuhan m. Neurodegener Dis Manag. 2018 Aug;8(4):267-282. doi: 10.2217/nmt-2018-0010. Epub 2018 Jul 24. Neurodegener Dis Manag. 2018. PMID: 30040024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters